Literature DB >> 29238866

Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.

Li Xu1, Yangyang Duanmu1, Glen M Blake2, Chenxin Zhang1, Yong Zhang1, Keenan Brown3, Xiaoqi Wang4, Peng Wang5, Xingang Zhou5, Manling Zhang6, Chao Wang7, Zhe Guo1, Giuseppe Guglielmi8, Xiaoguang Cheng9.   

Abstract

OBJECTIVES: This study aimed to validate the accuracy and reliability of quantitative computed tomography (QCT) and chemical shift encoded magnetic resonance imaging (CSE-MRI) to assess hepatic steatosis.
METHODS: Twenty-two geese with a wide range of hepatic steatosis were collected. After QCT and CSE-MRI examinations, the liver of each goose was removed and samples were taken from the left lobe, upper and lower half of the right lobe for biochemical measurement and histology. Fat percentages by QCT and proton density fat fraction by MRI (MRI-PDFF) were measured within the sample regions of biochemical measurement and histology. The accuracy of QCT and MR measurements were assessed through Spearman correlation coefficients (r) and Passing and Bablok regression equations using biochemical measurement as the "gold standard".
RESULTS: Both QCT and MRI correlated highly with chemical extraction [r = 0.922 (p < 0.001) and r = 0.949 (p < 0.001) respectively]. Chemically extracted triglyceride was accurately predicted by both QCT liver fat percentages (Y = 0.6 + 0.866 × X) and by MRI-PDFF (Y = -1.8 + 0.773 × X).
CONCLUSIONS: QCT and CSE-MRI measurements of goose liver fat were accurate and reliable compared with biochemical measurement. KEY POINTS: • QCT and CSE-MRI can measure liver fat content accurately and reliably • Histological grading of hepatic steatosis has larger sampling variability • QCT and CSE-MRI have potential in the clinical setting.

Entities:  

Keywords:  Chemical shift encoded magnetic resonance imaging; Hepatic steatosis; Hepatic triglyceride analysis; Proton density fat fraction; Quantitative computed tomography

Mesh:

Year:  2017        PMID: 29238866     DOI: 10.1007/s00330-017-5189-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  44 in total

1.  Dual-echo Dixon imaging with flexible choice of echo times.

Authors:  Holger Eggers; Bernhard Brendel; Adri Duijndam; Gwenael Herigault
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

2.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  Two-point dixon method with flexible echo times.

Authors:  Johan Berglund; Håkan Ahlström; Lars Johansson; Joel Kullberg
Journal:  Magn Reson Med       Date:  2010-11-16       Impact factor: 4.668

4.  Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT.

Authors:  Yang Shin Park; Seong Ho Park; Seung Soo Lee; Dae Yoon Kim; Yong Moon Shin; Woochang Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

5.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Authors:  Christopher D Williams; Joel Stengel; Michael I Asike; Dawn M Torres; Janet Shaw; Maricela Contreras; Cristy L Landt; Stephen A Harrison
Journal:  Gastroenterology       Date:  2010-09-19       Impact factor: 22.682

6.  Measurement of Body and Liver Fat in Small Animals Using Peripheral Quantitative Computed Tomography.

Authors:  Tim R Nagy; Maria S Johnson
Journal:  Int J Body Compos Res       Date:  2004-01-01

7.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

8.  Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Authors:  Peter Bannas; Harald Kramer; Diego Hernando; Rashmi Agni; Ashley M Cunningham; Rakesh Mandal; Utaroh Motosugi; Samir D Sharma; Alejandro Munoz del Rio; Luis Fernandez; Scott B Reeder
Journal:  Hepatology       Date:  2015-09-28       Impact factor: 17.425

9.  Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse.

Authors:  Nathan S Artz; Catherine D G Hines; Stephen T Brunner; Rashmi M Agni; Jens-Peter Kühn; Alejandro Roldan-Alzate; Guang-Hong Chen; Scott B Reeder
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

10.  Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice.

Authors:  Catherine D G Hines; Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Thomas F Warner; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

View more
  7 in total

Review 1.  Topics on quantitative liver magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Xiaoqi Wang; Peng Wu; Yajie Wang; Weibo Chen; Huijun Chen; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2019-11

2.  Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).

Authors:  Adrija Mamidipalli; Kathryn J Fowler; Gavin Hamilton; Tanya Wolfson; Yesenia Covarrubias; Calvin Tran; Soudabeh Fazeli; Curtis N Wiens; Alan McMillan; Nathan S Artz; Luke M Funk; Guilherme M Campos; Jacob A Greenberg; Anthony Gamst; Michael S Middleton; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin
Journal:  Eur Radiol       Date:  2020-04-21       Impact factor: 5.315

Review 3.  How to best assess abdominal obesity.

Authors:  Hongjuan Fang; Elizabeth Berg; Xiaoguang Cheng; Wei Shen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-09       Impact factor: 4.294

4.  MRI liver fat quantification in an oncologic population: the added value of complex chemical shift-encoded MRI.

Authors:  Giuseppe Corrias; Simone Krebs; Sarah Eskreis-Winkler; Davinia Ryan; Junting Zheng; Marinela Capanu; Luca Saba; Serena Monti; Maggie Fung; Scott Reeder; Lorenzo Mannelli
Journal:  Clin Imaging       Date:  2018-08-08       Impact factor: 1.605

5.  Pancreatic Fat is not significantly correlated with β-cell Dysfunction in Patients with new-onset Type 2 Diabetes Mellitus using quantitative Computed Tomography.

Authors:  Y X Li; Y Q Sang; Yan Sun; X K Liu; H F Geng; Min Zha; Ben Wang; Fei Teng; H J Sun; Yu Wang; Q Q Qiu; Xiu Zang; Yun Wang; T T Wu; Peter M Jones; Jun Liang; Wei Xu
Journal:  Int J Med Sci       Date:  2020-07-02       Impact factor: 3.738

Review 6.  Recent Issues on Body Composition Imaging for Sarcopenia Evaluation.

Authors:  Koeun Lee; Yongbin Shin; Jimi Huh; Yu Sub Sung; In Seob Lee; Kwon Ha Yoon; Kyung Won Kim
Journal:  Korean J Radiol       Date:  2019-02       Impact factor: 3.500

7.  Quantification of Fat Metaplasia in the Sacroiliac Joints of Patients With Axial Spondyloarthritis by Chemical Shift-Encoded MRI: A Diagnostic Trial.

Authors:  Dong Liu; Churong Lin; Budian Liu; Jun Qi; Huiquan Wen; Liudan Tu; Qiujing Wei; Qingcong Kong; Ya Xie; Jieruo Gu
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.